Hpv Vaccine Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20 mcg, 30 mcg, 40 mcg
Reference Brands: Gardasil (USA/EU), Cervarix (EU), Cervavac (India)
Category:
Vaccines
Human papillomavirus vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available HPV vaccines protect against either two, four, or nine types of HPV. All HPV vaccines protect against at least HPV types 16 and 18, which cause the greatest risk of cervical cancer.
HPV VACCINE is available in Injection
and strengths such as 20 mcg, 30 mcg, 40 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, HPV VACCINE is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
HPV VACCINE can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Human Papillomavirus (HPV) Vaccine is a preventive vaccine designed to protect the body against infections caused by certain types of human papillomavirus (HPV). HPV is a common virus that spreads through close skin-to-skin contact and can lead to abnormal tissue growth such as genital warts and cellular changes in the body. Persistent infection with high-risk HPV types can increase the risk of developing several cancers, including cancers of the cervix, vagina, vulva, anus, penis, and oropharynx.
HPV vaccines are developed using recombinant technology and contain virus-like particles that stimulate the immune system to recognize and fight the virus without causing infection. By generating protective antibodies, the vaccine helps prevent HPV infection and reduces the risk of HPV-related diseases and cancers.
The vaccine is widely recommended for adolescents and young adults as part of routine immunization programs, ideally before exposure to the virus. HPV vaccination also plays an important role in public health strategies aimed at reducing the global burden of cervical cancer and other HPV-associated cancers. In addition to cancer prevention, HPV vaccines help prevent genital warts and precancerous lesions that may develop into cancer if left untreated.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing